Pages Menu
TwitterRssFacebook
Categories Menu

Posted by on Sep 21, 2009 | 1 comment

FDA warns Allergan Website too Skimpy on Latisse Warnings

The makers of Latisse can’t bat their lashes out of this one.
latissebrookeshields

Latisse mascara, developed by Allergan Inc. from glaucoma medication, triggers eyelashes to grow at a quick rate and is approved for “thicker, fuller and darker” lashes. The Food and Drug Administration, however, has given the company a warning for their website and promo materials for failing to promote the side effects of the products as well as the intended benefits.

In my post from January on Latisse’s release I mentioned a few of the issues the medication could cause,  and here is another rundown:

  • Permanent darkening of blues eyes to brown
  • Irritation
  • Bacterial eye infection
  • Excess hair growth outside treatment area

It was found that Latisse warnings were sometimes missing on the website while present on other materials.  The FDA has asked Allergan to stop using all current promotional materials that omit the information of these potentially serious side effects and to respond to the agency by September 24th.

latisseinfoIf you weren’t aware of these issues before, does an awareness stop you from using or potentially using the product?

Share
Featured in Alltop

1 Comment

  1. I’ve used Latisse for 8 weeks and totally noticed results. My daughter said my lashes were so long they looked like spiders I guess that’s a good thing? The medspa I go to is a total ripoff trying to charge $120 a bottle. I found a place to order online for $12.50 + shipping. Same stuff just the generic version. They also have Retin-A for like $5 a tube for the good Retin-A micro stuff. I can’t believe the Dr’s offices try to rip people off by charging soooooo much for a little tiny bottle of solution!

Post a Reply